The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Carcinoma, Lobular

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Carcinoma, Lobular


High impact information on Carcinoma, Lobular


Chemical compound and disease context of Carcinoma, Lobular


Biological context of Carcinoma, Lobular


Anatomical context of Carcinoma, Lobular


Gene context of Carcinoma, Lobular


Analytical, diagnostic and therapeutic context of Carcinoma, Lobular


  1. Breast cancer prevention: a review of current evidence. Vogel, V.G. CA: a cancer journal for clinicians. (2000) [Pubmed]
  2. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells. Krop, I.E., Sgroi, D., Porter, D.A., Lunetta, K.L., LeVangie, R., Seth, P., Kaelin, C.M., Rhei, E., Bosenberg, M., Schnitt, S., Marks, J.R., Pagon, Z., Belina, D., Razumovic, J., Polyak, K. Proc. Natl. Acad. Sci. U.S.A. (2001) [Pubmed]
  3. Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. Nielsen, B.S., Rank, F., López, J.M., Balbin, M., Vizoso, F., Lund, L.R., Danø, K., López-Otín, C. Cancer Res. (2001) [Pubmed]
  4. Expression of thrombospondin (TSP1) and its receptors (CD36 and CD51) in normal, hyperplastic, and neoplastic human breast. Clezardin, P., Frappart, L., Clerget, M., Pechoux, C., Delmas, P.D. Cancer Res. (1993) [Pubmed]
  5. Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas. Moll, R., Mitze, M., Frixen, U.H., Birchmeier, W. Am. J. Pathol. (1993) [Pubmed]
  6. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A., Weinberg, R.A. Cell (2004) [Pubmed]
  7. Frequent overexpression of the cyclin D1 oncogene in invasive lobular carcinoma of the breast. Oyama, T., Kashiwabara, K., Yoshimoto, K., Arnold, A., Koerner, F. Cancer Res. (1998) [Pubmed]
  8. Expression of and response to interleukin 6 (IL6) in human mammary tumors. Basolo, F., Fiore, L., Fontanini, G., Conaldi, P.G., Calvo, S., Falcone, V., Toniolo, A. Cancer Res. (1996) [Pubmed]
  9. Aromatase and 17 beta-hydroxysteroid dehydrogenase type 1 in human breast carcinoma. Sasano, H., Frost, A.R., Saitoh, R., Harada, N., Poutanen, M., Vihko, R., Bulun, S.E., Silverberg, S.G., Nagura, H. J. Clin. Endocrinol. Metab. (1996) [Pubmed]
  10. National surgical adjuvant breast and bowel project update: prevention trials and endocrine therapy of ductal carcinoma in situ. Vogel, V.G., Costantino, J.P., Wickerham, D.L., Cronin, W.M. Clin. Cancer Res. (2003) [Pubmed]
  11. Hypermethylation of calcitonin gene regulatory sequences in human breast cancer as revealed by genomic sequencing. Hakkarainen, M., Wahlfors, J., Myöhänen, S., Hiltunen, M.O., Eskelinen, M., Johansson, R., Jänne, J. Int. J. Cancer (1996) [Pubmed]
  12. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Palacios, J., Sarrió, D., García-Macias, M.C., Bryant, B., Sobel, M.E., Merino, M.J. Mod. Pathol. (2003) [Pubmed]
  13. Risk factors for carcinoma in situ of the breast. Trentham-Dietz, A., Newcomb, P.A., Storer, B.E., Remington, P.L. Cancer Epidemiol. Biomarkers Prev. (2000) [Pubmed]
  14. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Berx, G., Cleton-Jansen, A.M., Nollet, F., de Leeuw, W.J., van de Vijver, M., Cornelisse, C., van Roy, F. EMBO J. (1995) [Pubmed]
  15. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma. Anderson, W.F., Chu, K.C., Chang, S., Sherman, M.E. Cancer Epidemiol. Biomarkers Prev. (2004) [Pubmed]
  16. Point mutation of the E-cadherin gene in invasive lobular carcinoma of the breast. Kanai, Y., Oda, T., Tsuda, H., Ochiai, A., Hirohashi, S. Jpn. J. Cancer Res. (1994) [Pubmed]
  17. Lobular carcinoma of the male breast associated with the use of cimetidine. San Miguel, P., Sancho, M., Enriquez, J.L., Fernandez, J., Gonzalez-Palacios, F. Virchows Arch. (1997) [Pubmed]
  18. Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas. Bukholm, I.K., Nesland, J.M., Kåresen, R., Jacobsen, U., Børresen-Dale, A.L. Virchows Arch. (1997) [Pubmed]
  19. E-cadherin quantitative immunocytochemical assays in breast carcinomas. Charpin, C., Garcia, S., Bouvier, C., Devictor, B., Andrac, L., Choux, R., Lavaut, M. J. Pathol. (1997) [Pubmed]
  20. B7-h4 is highly expressed in ductal and lobular breast cancer. Tringler, B., Zhuo, S., Pilkington, G., Torkko, K.C., Singh, M., Lucia, M.S., Heinz, D.E., Papkoff, J., Shroyer, K.R. Clin. Cancer Res. (2005) [Pubmed]
  21. Expression of gap junction proteins connexin 26 and connexin 43 in normal human breast and in breast tumours. Jamieson, S., Going, J.J., D'Arcy, R., George, W.D. J. Pathol. (1998) [Pubmed]
  22. Alveolar variant of invasive lobular carcinoma of the breast. A tumor rich in estrogen receptors. Shousha, S., Backhous, C.M., Alaghband-Zadeh, J., Burn, I. Am. J. Clin. Pathol. (1986) [Pubmed]
  23. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer. Nielsen, B.S., Sehested, M., Timshel, S., Pyke, C., Danø, K. Lab. Invest. (1996) [Pubmed]
  24. Bone sialoprotein expression in primary human breast cancer is associated with bone metastases development. Bellahcene, A., Kroll, M., Liebens, F., Castronovo, V. J. Bone Miner. Res. (1996) [Pubmed]
  25. Serum vascular endothelial growth factor in breast cancer: its relation with cancer type and estrogen receptor status. Heer, K., Kumar, H., Read, J.R., Fox, J.N., Monson, J.R., Kerin, M.J. Clin. Cancer Res. (2001) [Pubmed]
  26. PIK3CA mutation and histological type in breast carcinoma: high frequency of mutations in lobular carcinoma. Buttitta, F., Felicioni, L., Barassi, F., Martella, C., Paolizzi, D., Fresu, G., Salvatore, S., Cuccurullo, F., Mezzetti, A., Campani, D., Marchetti, A. J. Pathol. (2006) [Pubmed]
  27. HMGA1 protein overexpression in human breast carcinomas: correlation with ErbB2 expression. Chiappetta, G., Botti, G., Monaco, M., Pasquinelli, R., Pentimalli, F., Di Bonito, M., D'Aiuto, G., Fedele, M., Iuliano, R., Palmieri, E.A., Pierantoni, G.M., Giancotti, V., Fusco, A. Clin. Cancer Res. (2004) [Pubmed]
  28. Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy. Mottolese, M., Benevolo, M., Del Monte, G., Buglioni, S., Papaldo, P., Nisticò, C., Di Filippo, F., Vasselli, S., Vici, P., Botti, C. J. Cancer Res. Clin. Oncol. (2000) [Pubmed]
WikiGenes - Universities